As The Revolving Door Turns: Trump Official Leaves FDA For Biopharma Company
Latest Move Shows Big Pharma’s Revolving Door to the Trump Administration WASHINGTON — A top Food and Drug Administration (FDA) ... Read More
Questions For Big Pharma As Drug Execs Cozy Up To The Administration
The Pharmaceutical Industry Remains an Overwhelming Force in Trump and Azar’s Washington WASHINGTON — Big Pharma’s top executives are back ... Read More
Sec. Chao: Conflicts of Interest at 30,000 Feet
Chao Appoints Boeing Exec to Safety Oversight Committee, FAA Hints at Ungrounding Boeing 737 MAX WASHINGTON, D.C. – Today, Transportation ... Read More
Amid Azar’s Drug Pricing Failures, One in Four Diabetics Asked for a Cheaper Alternative
WASHINGTON — In the absence of meaningful action on drug pricing from HHS Secretary Azar and the Trump administration, a ... Read More